Search U.S. Product Recalls Database

Showing 14601–14620 of 15081 results

Sort:

Caziant Tablets (Watson Laboratories) – Impurity Concern (2012)

Impurities/Degradation Products: Out-of-specification results were obtained for a known impurities.

FDADec 13, 2012Nationwide• Watson Laboratories Inc

Temodar Capsules (Schering-Plough) – Degradation Failure (2012)

Failed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the degradation product testing detected during stability monitoring.

Class IIModerate

FDADec 12, 2012Nationwide• Schering-Plough Products, LLC

Stay Informed

Search Product Recalls

Caziant Tablets (Watson Laboratories) – Impurity Concern (2012)

Temodar Capsules (Schering-Plough) – Degradation Failure (2012)

Perindopril Erbumine Tablets (Boehringer Ingelheim) – Impurity Risk (2012)

Divalproex Sodium Tablets (Upsher Smith) – Labeling Error (2012)

WOW Health Supplement (Brower Enterprises) – Undeclared Ingredients (2012)

Carisoprodol Tablets (West-ward) - black tablet spots (2012)

Lisinopril Tablets (West-ward Pharmaceutical) – Foreign Substance (2012)

Propylthiouracil Tablets (West-ward) - steel corrosion spots (2012)

Hydrocodone Acetaminophen (Qualitest) - oversized tablets (2012)

Copaxone (Teva) - visible metal contamination (2012)

Oxygen Medical Gas (Oklahoma Respiratory) - impurity specification (2012)

PredniSONE Tablets (West-ward) - black specks (2012)

Protandim Supplement (Lifevantage) – Metal Fragment Risk (2012)

PredniSONE Tablets (West-ward) - gray tablet defects (2012)

Cyanocobalamin Injection (Green Valley) - non-sterile (2012)

Isoniazid Tablets (West-ward) - dissolution specification (2012)

Methylprednisolone Injection (Green Valley) - non-sterile (2012)

Dextroamphetamine Capsules (Amedra) - dissolution failure (2012)

Dextroamphetamine Capsules (Amedra) - dissolution failure (2012)

Synthroid (Abbott) - strength labeling error (2012)